Diaz Luis 4
4 · Jounce Therapeutics, Inc. · Filed Oct 23, 2017
Insider Transaction Report
Form 4
Diaz Luis
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-10-20+27,100→ 27,100 totalExercise: $14.78Exp: 2027-10-20→ Common Stock (27,100 underlying)
Footnotes (1)
- [F1]This option was granted on October 20, 2017 and will vest in equal quarterly installments during the twelve quarters following the grant date.